Swollen lymph nodes serve as a crucial early warning system when the body fights HIV. These changes often appear subtle at first but persist beyond the duration of typical viral infections.
10h
LGBTQ Nation on MSNOnce-a-year shot for HIV protection passes early safety trialAn annual shot to protect against HIV infection has successfully passed an early safety trial, according to research published in The Lancet medical journal. The drug lenacapavir passed a critical ...
Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...
Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...
Explore how sexually transmitted infections progress, symptoms to watch for, and prevention strategies to protect sexual ...
Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...
The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...
Early diagnosis and prompt antiretroviral therapy initiation are critical for children due to the rapid progression of HIV in ...
Older adults with HIV are at significantly higher risk for cutaneous malignancies when compared with younger patients with HIV.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results